Genitourinary Cancers: From Molecular Pathogenesis to Precision Diagnosis and Therapy
A Special Issue of Biomedicines (ISSN 2227-9059) belonging to the section "Cancer Biology and Oncology".
Deadline for manuscript submissions: 31 January 2027 | Viewed by 1278
Editors
Interests: prostate cancer; bladder cancer; PROTAC; extracellular vesicles; oncolytic virus; IRE
Interests: prostate cancer; extracellular vesicles; oncolytic virus; fluorescence-guided surgery
Special Issue Information
Dear Colleagues,
This Special Issue, “Genitourinary Cancers: From Molecular Pathogenesis to Precision Diagnosis and Therapy”, will mainly focus on the integration of pathophysiology, diagnostic innovation, and therapeutic advances for prostate, bladder, renal, and testicular malignancies.
Until a few years ago, the treatment of genitourinary tumors relied primarily on surgery, cytotoxic chemotherapy, and radiation. Recently, targeted therapies, immune checkpoint inhibitors, and PARP inhibitors have transformed clinical outcomes, yet drug resistance and disease recurrence remain critical challenges. Investigators have started to realize that a deeper understanding of tumor pathobiology, coupled with multi-omics and AI-driven diagnostics, is essential in developing next-generation precision therapies and overcoming therapeutic resistance.
We cordially invite authors in this field to submit original research or review articles pertaining to this important and rapidly progressing field of biomedicine.
Dr. Qi-Dong Xia
Dr. Jian-Xuan Sun
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- genitourinary tumors
- molecular pathogenesis
- tumor microenvironment
- biomarkers
- liquid biopsy
- immunotherapy
- targeted therapy
- therapy resistance
- precision diagnosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
